1.61 +0.00 (0.00%)
SNSS
| Trade SNSS now with |
|
Stock Details
Last Trade:1.61 Change:+0.00 (0.00%) Prev Close:1.61 Open: 1.61 Days Range:1.61 – 1.65 52 Week Range: 0.36 - 3.16 Volume:141521 P/E: N/AEPS:-0.46
View AllRecent Alerts 02/09/12
Recent Alert on 02/02/12 at 4:02pm
Sunesis Pharmaceuticals (SNSS) Appoints Adam R. Craig as Chief Medical Officer
Sunesis Pharmaceuticals (SNSS) Appoints Adam R. Craig as Chief Medical Officer
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced the appointment of Adam R. Craig, M.B.B.S., Ph.D., M.B.A. to the newly created position of Executive Vice President, Development and Chief Medical Officer, effective March 1, 2012. In this... Read More
Recent Alert on 12/12/11 at 7:10am
Sunesis Pharmaceuticals (SNSS) Participates in Phase 2/3 Trial Evaluating Vosaroxin
Sunesis Pharmaceuticals (SNSS) Participates in Phase 2/3 Trial Evaluating Vosaroxin
View AllRecent Press Releases
Press Release on 02/07/12 at 7:00am
Sunesis to Present at the 14th Annual BIO CEO & Investor Conference
Sunesis to Present at the 14th Annual BIO CEO & Investor Conference
View AllRecent SEC Filings
SEC Filing on 02/08/12 at 3:50pm
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: Merlin BioMed Private Equity Advisors, L.L.C.
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: Merlin BioMed Private Equity Advisors, L.L.C.